Health News

Immune Diseases Were More Common in Those Born by C-Section
Could the birth process have a role in immune disease development? A common birthing method may raise babies' risk of immune diseases later, a new study found.
FDA Expands Approval of Rx for Rare Blood and Bone Disease
Earlier this year, the US Food and Drug Administration (FDA) gave a speedy approval to a new medication to treat a rare blood disease. Now, the FDA has expanded that approval.
FDA Approves New Cancer Medication
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
Many Minority Kids With Cancer Missed Needed Medication
Children in remission from leukemia, the most common childhood cancer, need to take a certain medication to keep the cancer from coming back. But some of these children are not receiving all the medication they need.
Mega-Dose of Measles Vaccine Killed Cancer
Multiple myeloma is a cancer that develops in the bone marrow and is considered by many to be incurable. An engineered measles virus, however, may change that.
Why Childhood Cancer Survival Rates Have Increased
With increasing survival rates for many types of childhood cancers, some of these cancers are approaching cures. Several key events have made this possible.
Traffic May be Deadly, But Not the Way You’d Expect
Many people consider living near traffic to be dangerous for children, fearing accidents. New research suggests that traffic can be harmful to children for other reasons.
Turning Leukemia into a Highly Treatable Disease
Chemotherapy is a standard treatment for the most common form of leukemia — chronic lymphocytic leukemia (CLL). A combination of pills may offer CLL patients new, better and gentler options.
Hodgkin Lymphoma Treatment May Boost Breast Cancer Risks
The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.
Rx May Offer Hope for Some Non-Hodgkin Lymphoma Patients
Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.